Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Alessandra Vultaggio and Fabio Almerigogna.
Alessandra Vultaggio
Connection Strength
0.798
Fabio Almerigogna
  1. Can SSRI/SNRI antidepressants decrease the 'cytokine storm' in the course of COVID-19 pneumonia? Panminerva Med. 2021 Jul 09.
    View in: PubMed
    Score: 0.239
  2. COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey. Allergy. 2021 03; 76(3):871-874.
    View in: PubMed
    Score: 0.224
  3. Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study. J Allergy Clin Immunol Pract. 2020 Sep; 8(8):2575-2581.e2.
    View in: PubMed
    Score: 0.222
  4. Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19. Allergy Rhinol (Providence). 2020 Jan-Dec; 11:2152656720968804.
    View in: PubMed
    Score: 0.057
  5. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020 09 01; 130(9):4694-4703.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.